Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Other Equity
Yield10 Bioscience Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Other Equity
-$265k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-10%
|
|
Abbvie Inc
NYSE:ABBV
|
Other Equity
-$2.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Equity
$17.5B
|
CAGR 3-Years
672%
|
CAGR 5-Years
158%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Equity
-$190m
|
CAGR 3-Years
39%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Equity
-$23.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Equity
-$77.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Other Equity?
Other Equity
-265k
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Other Equity amounts to -265k USD.
What is Yield10 Bioscience Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-10%
Over the last year, the Other Equity growth was -33%. The average annual Other Equity growth rates for Yield10 Bioscience Inc have been -10% over the past three years , -22% over the past five years , and -10% over the past ten years .